Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children.
D000962:Antimalarials / Q000627:therapeutic use*; D002648:Child; D002981:Clindamycin / Q000009:adverse effects / Q000627:therapeutic use*; D015331:Cohort Studies; D004359:Drug Therapy, Combination; D005578:Fosfomycin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005681:Gabon; D006454:Hemoglobins / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy*; D012107:Research Design
D000962:Antimalarials; D006454:Hemoglobins; D005578:Fosfomycin; D002981:Clindamycin; C024640:fosmidomycin